QUANTERIX CORP (QTRX) Stock Fundamental Analysis

NASDAQ:QTRX • US74766Q1013

5.74 USD
-0.15 (-2.55%)
At close: Feb 13, 2026
5.74 USD
0 (0%)
After Hours: 2/13/2026, 8:00:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

QTRX gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 58 industry peers in the Life Sciences Tools & Services industry. The financial health of QTRX is average, but there are quite some concerns on its profitability. QTRX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year QTRX has reported negative net income.
  • In the past year QTRX has reported a negative cash flow from operations.
  • QTRX had negative earnings in each of the past 5 years.
  • QTRX had a negative operating cash flow in each of the past 5 years.
QTRX Yearly Net Income VS EBIT VS OCF VS FCFQTRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

  • QTRX's Return On Assets of -21.54% is on the low side compared to the rest of the industry. QTRX is outperformed by 68.97% of its industry peers.
  • The Return On Equity of QTRX (-30.41%) is worse than 60.34% of its industry peers.
Industry RankSector Rank
ROA -21.54%
ROE -30.41%
ROIC N/A
ROA(3y)-12.78%
ROA(5y)-12.3%
ROE(3y)-15.57%
ROE(5y)-15.02%
ROIC(3y)N/A
ROIC(5y)N/A
QTRX Yearly ROA, ROE, ROICQTRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200

1.3 Margins

  • With a Gross Margin value of 51.53%, QTRX perfoms like the industry average, outperforming 56.90% of the companies in the same industry.
  • QTRX's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for QTRX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 51.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.73%
GM growth 5Y5.05%
QTRX Yearly Profit, Operating, Gross MarginsQTRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • QTRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • QTRX has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for QTRX has been increased compared to 5 years ago.
  • There is no outstanding debt for QTRX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
QTRX Yearly Shares OutstandingQTRX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
QTRX Yearly Total Debt VS Total AssetsQTRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

  • QTRX has an Altman-Z score of -0.45. This is a bad value and indicates that QTRX is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of QTRX (-0.45) is worse than 72.41% of its industry peers.
  • QTRX has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of QTRX (0.00) is better than 72.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.45
ROIC/WACCN/A
WACC10.82%
QTRX Yearly LT Debt VS Equity VS FCFQTRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

  • QTRX has a Current Ratio of 3.02. This indicates that QTRX is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of QTRX (3.02) is comparable to the rest of the industry.
  • A Quick Ratio of 2.31 indicates that QTRX has no problem at all paying its short term obligations.
  • QTRX has a Quick ratio (2.31) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 3.02
Quick Ratio 2.31
QTRX Yearly Current Assets VS Current LiabilitesQTRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The earnings per share for QTRX have decreased strongly by -90.57% in the last year.
  • QTRX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -21.51%.
  • QTRX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.37% yearly.
EPS 1Y (TTM)-90.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-231.82%
Revenue 1Y (TTM)-21.51%
Revenue growth 3Y7.51%
Revenue growth 5Y19.37%
Sales Q2Q%12.34%

3.2 Future

  • QTRX is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.97% yearly.
  • QTRX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.03% yearly.
EPS Next Y-150.87%
EPS Next 2Y-14.33%
EPS Next 3Y-1.47%
EPS Next 5Y0.97%
Revenue Next Year-2.57%
Revenue Next 2Y11.8%
Revenue Next 3Y12.47%
Revenue Next 5Y16.03%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
QTRX Yearly Revenue VS EstimatesQTRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M
QTRX Yearly EPS VS EstimatesQTRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 -0.5 -1 -1.5 -2 -2.5

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • QTRX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year QTRX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
QTRX Price Earnings VS Forward Price EarningsQTRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
QTRX Per share dataQTRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-14.33%
EPS Next 3Y-1.47%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for QTRX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

QUANTERIX CORP

NASDAQ:QTRX (2/13/2026, 8:00:00 PM)

After market: 5.74 0 (0%)

5.74

-0.15 (-2.55%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-10
Earnings (Next)03-03
Inst Owners76.5%
Inst Owner Change-2%
Ins Owners1.17%
Ins Owner Change1.94%
Market Cap268.12M
Revenue(TTM)130.20M
Net Income(TTM)-95.66M
Analysts48.89
Price Target7.65 (33.28%)
Short Float %8.23%
Short Ratio4.5
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-45.13%
Min EPS beat(2)-55.23%
Max EPS beat(2)-35.04%
EPS beat(4)1
Avg EPS beat(4)-24.98%
Min EPS beat(4)-55.23%
Max EPS beat(4)5.7%
EPS beat(8)4
Avg EPS beat(8)-7.81%
EPS beat(12)7
Avg EPS beat(12)7.87%
EPS beat(16)9
Avg EPS beat(16)-1.48%
Revenue beat(2)1
Avg Revenue beat(2)-5.38%
Min Revenue beat(2)-14.99%
Max Revenue beat(2)4.23%
Revenue beat(4)3
Avg Revenue beat(4)-1.3%
Min Revenue beat(4)-14.99%
Max Revenue beat(4)5.44%
Revenue beat(8)6
Avg Revenue beat(8)0.08%
Revenue beat(12)9
Avg Revenue beat(12)3.12%
Revenue beat(16)12
Avg Revenue beat(16)1.73%
PT rev (1m)15.38%
PT rev (3m)20%
EPS NQ rev (1m)0%
EPS NQ rev (3m)9.4%
EPS NY rev (1m)0%
EPS NY rev (3m)3.68%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)-5.79%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)-0.21%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.06
P/FCF N/A
P/OCF N/A
P/B 0.85
P/tB 1.72
EV/EBITDA N/A
EPS(TTM)-2.02
EYN/A
EPS(NY)-1.35
Fwd EYN/A
FCF(TTM)-1.46
FCFYN/A
OCF(TTM)-1.39
OCFYN/A
SpS2.79
BVpS6.73
TBVpS3.34
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -21.54%
ROE -30.41%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 51.53%
FCFM N/A
ROA(3y)-12.78%
ROA(5y)-12.3%
ROE(3y)-15.57%
ROE(5y)-15.02%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.73%
GM growth 5Y5.05%
F-Score1
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 31.31%
Cap/Sales 2.4%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.02
Quick Ratio 2.31
Altman-Z -0.45
F-Score1
WACC10.82%
ROIC/WACCN/A
Cap/Depr(3y)110.86%
Cap/Depr(5y)140.92%
Cap/Sales(3y)5.57%
Cap/Sales(5y)6.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-90.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-231.82%
EPS Next Y-150.87%
EPS Next 2Y-14.33%
EPS Next 3Y-1.47%
EPS Next 5Y0.97%
Revenue 1Y (TTM)-21.51%
Revenue growth 3Y7.51%
Revenue growth 5Y19.37%
Sales Q2Q%12.34%
Revenue Next Year-2.57%
Revenue Next 2Y11.8%
Revenue Next 3Y12.47%
Revenue Next 5Y16.03%
EBIT growth 1Y-30.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year4.96%
EBIT Next 3Y-8%
EBIT Next 5YN/A
FCF growth 1Y-238.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-282.68%
OCF growth 3YN/A
OCF growth 5YN/A

QUANTERIX CORP / QTRX FAQ

Can you provide the ChartMill fundamental rating for QUANTERIX CORP?

ChartMill assigns a fundamental rating of 2 / 10 to QTRX.


What is the valuation status for QTRX stock?

ChartMill assigns a valuation rating of 0 / 10 to QUANTERIX CORP (QTRX). This can be considered as Overvalued.


What is the profitability of QTRX stock?

QUANTERIX CORP (QTRX) has a profitability rating of 1 / 10.


Can you provide the financial health for QTRX stock?

The financial health rating of QUANTERIX CORP (QTRX) is 4 / 10.